LECT2 and hepatocellular carcinoma: Furthermore, exogenous LECT2 or Ad-LECT2 administration effectively suppressed anchorage-independent growth, cell migration, and cell invasiveness companied with EMT inhibition in both rat and human hepatoma cells.